<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu B</submitter><funding>NCI NIH HHS</funding><pagination>612-619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10173871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(3)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Anaplastic thyroid carcinoma (ATC) is the most lethal form of thyroid cancer with most patients dying of their disease within a few months. Only a very small percentage of long-term survivors (LTS) are alive for 2 years or longer. In this retrospective case-control study, we provided a comprehensive comparison between 46 ATC LTSs and 75 ATC control patients who suffered disease-specific mortality within 2 years, aiming to identify factors that may be associated with prolonged survival in ATC.&lt;h4>Methods&lt;/h4>A comprehensive clinicopathologic and molecular comparison was performed between 46 ATC LTSs and 75 ATC control patients. Peripheral neutrophil count and neutrophil-to-lymphocyte ratio (NLR) were recorded. The composition of the tumor microenvironment was compared using </pubmed_abstract><journal>Endocrine</journal><pubmed_title>Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio.</pubmed_title><pmcid>PMC10173871</pmcid><funding_grant_id>R01 CA255211</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><pubmed_authors>Balzer B</pubmed_authors><pubmed_authors>Setoodeh R</pubmed_authors><pubmed_authors>Mohanty AS</pubmed_authors><pubmed_authors>Landa I</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Dogan S</pubmed_authors><pubmed_authors>Ghossein R</pubmed_authors><pubmed_authors>Tiedje V</pubmed_authors><pubmed_authors>Fagin JA</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Ganly I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio.</name><description>&lt;h4>Purpose&lt;/h4>Anaplastic thyroid carcinoma (ATC) is the most lethal form of thyroid cancer with most patients dying of their disease within a few months. Only a very small percentage of long-term survivors (LTS) are alive for 2 years or longer. In this retrospective case-control study, we provided a comprehensive comparison between 46 ATC LTSs and 75 ATC control patients who suffered disease-specific mortality within 2 years, aiming to identify factors that may be associated with prolonged survival in ATC.&lt;h4>Methods&lt;/h4>A comprehensive clinicopathologic and molecular comparison was performed between 46 ATC LTSs and 75 ATC control patients. Peripheral neutrophil count and neutrophil-to-lymphocyte ratio (NLR) were recorded. The composition of the tumor microenvironment was compared using </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-04T00:04:01.872Z</modification><creation>2024-11-20T12:15:30.684Z</creation></dates><accession>S-EPMC10173871</accession><cross_references><pubmed>35149932</pubmed><doi>10.1007/s12020-022-03008-9</doi></cross_references></HashMap>